

Amitiza (Lubiprostone) treats chronic constipation, IBS-C, and opioid-induced constipation. Learn about uses, dosage, cost, and more in 2026.
If your doctor has mentioned Amitiza — or you've been researching treatments for stubborn constipation — you probably have questions. What exactly is this medication? How does it work? What does it cost? This guide covers everything you need to know about Amitiza in 2026.
Amitiza is the brand name for Lubiprostone, a prescription medication in a class called chloride channel activators. It was originally developed and marketed by Takeda Pharmaceuticals (manufactured by Mallinckrodt Pharmaceuticals).
Amitiza is available as a soft gelatin capsule in two strengths:
It is not a controlled substance, which means it doesn't carry the prescribing restrictions that medications like opioids do. A generic version (Lubiprostone) became available after Amitiza's patent expired around 2024-2025.
To understand the science behind how it works, see our article on how Amitiza works.
Amitiza is FDA-approved for three conditions:
"Chronic idiopathic constipation" means long-term constipation with no identifiable underlying cause. If you've had infrequent, difficult, or incomplete bowel movements for months and over-the-counter treatments haven't helped, your doctor may consider Amitiza.
IBS-C is a type of irritable bowel syndrome where constipation is the primary symptom, often accompanied by bloating and abdominal pain. Amitiza is FDA-approved for IBS-C specifically in women aged 18 and older. It has not been sufficiently studied in men with IBS-C for that indication.
Opioid medications are well-known for causing constipation. If you take opioids for chronic pain (not related to cancer) and standard laxatives aren't enough, Amitiza can help restore more normal bowel function.
Amitiza is taken orally, twice daily, with food and water. Here are the standard doses by condition:
Important: Swallow the capsules whole. Do not break or chew them. Taking Amitiza with food is important — it significantly reduces the risk of nausea, which is the most common side effect.
If you have liver problems, your doctor may prescribe a lower dose. For moderate hepatic impairment with CIC, the typical adjusted dose is 16 mcg twice daily. For severe hepatic impairment, it may be reduced to 8 mcg twice daily.
Amitiza is not appropriate for everyone. You should not take it if you have:
Amitiza should not be used during pregnancy. Animal studies showed fetal loss at the recommended human dose. If you could become pregnant, your doctor should:
If you become pregnant while taking Amitiza, stop the medication and contact your doctor immediately.
For a full list of medications to be cautious about while taking Amitiza, read our guide on Amitiza drug interactions.
Cost is a real consideration with this medication:
The availability of generic Lubiprostone has made this medication significantly more affordable for many patients. However, not all pharmacies stock the generic, so you may need to shop around.
Most insurance plans cover Amitiza or its generic, but often require:
Brand Amitiza is typically Tier 3 or specialty tier on most formularies. Generic Lubiprostone may be Tier 2, with a lower copay.
There are several ways to bring down the cost:
For a complete breakdown, see our guide on how to save money on Amitiza.
Amitiza is a well-established treatment for chronic constipation, IBS-C, and opioid-induced constipation. With generic Lubiprostone now available, it's more accessible and affordable than ever. If you think Amitiza might be right for you, talk to your doctor about whether it fits your symptoms and medical history.
Ready to fill your prescription? Use Medfinder to find a pharmacy near you that has Amitiza in stock.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.